Status:
UNKNOWN
Immune Function Monitoring and Immunotherapy in Sepsis
Lead Sponsor:
Sun Yat-sen University
Conditions:
Sepsis
Septic Shock
Eligibility:
All Genders
18+ years
Brief Summary
At present, the clinical studies of various anti-inflammatory drugs and immune-enhancing drugs show that immunotherapy will bring new hope for the treatment of sepsis. In order to further understand t...
Eligibility Criteria
Inclusion
- Patients with sepsis or septic shock according to Sepsis 3.0
Exclusion
- None
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 30 2021
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT04903405
Start Date
June 1 2021
End Date
July 30 2021
Last Update
May 26 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.